Allurion Technologies (ALURW) Gross Margin (2022 - 2026)

Allurion Technologies (ALURW) reported Gross Margin of 41.7% for Q1 2026, down 3287.0% on a YoY basis from 1.31% in Q1 2025, and down 6.3% quarter-over-quarter from 44.51% in Q4 2025.

Allurion Technologies (ALURW) Gross Margin (2022 - 2026) Analysis & Trends

Allurion Technologies has reported Gross Margin for 5 years, with the latest figure at 41.7% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 3287.0% year-over-year to 41.7%; the trailing twelve-month figure through Mar 2026 stood at 52.7% (down 1372.0% YoY), and the FY2025 full-year result was 62.84%, down 412.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 41.7%, down from 44.51% in the prior quarter.
  • The five-year high for Gross Margin was 79.46% in Q4 2022, with the low at 41.7% in Q1 2026.
  • Historically, Gross Margin has averaged 67.74% across 5 years, with a median of 75.5% in 2024.
  • Annual changes were most pronounced in 2025 — Gross Margin surged 142 bps — and 2026, when it sank 3287 bps.
  • Allurion Technologies' Gross Margin stood at 79.46% in 2022, then fell by 2 bps to 78.08% in 2023, then slumped by 42 bps to 45.3% in 2024, then slipped by 2 bps to 44.51% in 2025, then dropped by 6 bps to 41.7% in 2026.
  • The last three Gross Margin figures came in at 41.7% (Q1 2026), 44.51% (Q4 2025), and 49.06% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 56.20%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 63.29%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 63.83%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 38.53%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 43.89%
10 Allurion Technologies - - 1.23 Mn 41.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 41.70%
Dec 31, 2025 44.51%
Sep 30, 2025 49.06%
Jun 30, 2025 73.90%
Mar 31, 2025 74.57%
Dec 31, 2024 45.30%
Sep 30, 2024 57.97%
Jun 30, 2024 76.43%
Mar 31, 2024 73.15%
Dec 31, 2023 78.08%
Sep 30, 2023 76.75%
Jun 30, 2023 76.91%
Mar 31, 2023 79.11%
Dec 31, 2022 79.46%
Sep 30, 2022 78.37%
Jun 30, 2022 78.49%